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What's new? 
 The socio-economic gradient in mortality within the general population and in type
2 diabetes is established. Scandinavian population-based cohort studies of people
with type 1 diabetes have reported an inverse association between socio-economic
status and mortality but there are no contemporary data for the UK.
 This study found that socio-economic deprivation was associated with higher
mortality in people with type 1 diabetes in Scotland, that the effect of deprivation
was larger than in the general population and that inequalities appear to be
widening over time.
 Effective interventions to reduce socio-economic inequalities in outcomes of type 1
diabetes are required.
Abstract 
Aims To describe the association between socio-economic status and mortality in a nation-
wide cohort of people with type 1 diabetes in Scotland and to compare patterns over time 
and with the general population. 
Methods A retrospective cohort study was performed using data for people with type 1 
diabetes from a population-based register linked to mortality records. Socio-economic 
status was derived from quintiles of an area-based measure: the Scottish Index of Multiple 
Deprivation.  Sex-specific directly age-standardized mortality rates for each Scottish Index 
of Multiple Deprivation quintile and rate ratios comparing the most vs least deprived 
quintile were calculated for two time periods: 2006–2010 and 2011–2015. Data for the 
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Results Data for 3802 deaths among 33 547 people with type 1 diabetes were available. 
The age-standardized mortality rate  per 1000 person-years decreased over time (from 
2006–2010 to 2011–2015) for men and women with type 1 diabetes: 24.8 to 20.2 and 22.5 
to 17.6, respectively. Mortality in populations with and without type 1 diabetes was 
generally higher for men than women and was inversely associated with socio-economic 
status. Rate ratios for the most vs least deprived groups increased over time among people 
with type 1 diabetes (men: 2.49 to 2.81; women: 1.92 to 2.86) and were higher than among 
populations without type 1 diabetes in 2011–2015 (men: 2.06; women: 1.66). 
Conclusions Socio-economic deprivation was associated with a steeper mortality gradient 
in people with type 1 diabetes than in the population without type 1 diabetes in Scotland. 
Age-standardized mortality has decreased over time but socio-economic inequalities may 
be increasing.  
 
Introduction  
Socio-economic gradients in morbidity and mortality within the general population and in 
type 2 diabetes mellitus are well established [1–3]. People from low socio-economic 
backgrounds have lower life expectancy and greater morbidity compared to more affluent 
peers, which has been attributed to a combination of financial, social and behavioural 
factors [4]. In the past two decades, improvements in life expectancy have occurred across 
the UK but the difference between the most and least affluent groups appears to be 
increasing [5,6]. It has been hypothesized that these inequalities may disproportionately 
affect those with chronic diseases, such as type 1 diabetes [7].   
 
The evidence for an association between socio-economic status (SES) and outcome in type 
1 diabetes is limited. Since the pathophysiology and management of type 1 and type 2 
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Population-based studies of people with type 1 diabetes performed in Sweden and Finland 
found an inverse association between SES, measured using individual measures such as 
income and education level, and mortality [8,9]. Few studies have compared the SES 
gradient in mortality in populations with type 1 diabetes with those in populations with 
type 2 diabetes and in populations without diabetes. Studies from Italy and the USA have 
demonstrated larger SES gradients in mortality in people with type 1 diabetes than in these 
other populations, but a Finnish study found little difference [10–12]. The association 
between SES and outcomes of type 1 diabetes in the UK is unclear. Only a small number 
of studies have been conducted [13–16]. Most of these studies were small, cross-sectional 
studies from the late 1990s, and focused on aspects of morbidity or diabetic management. 
Only one study has investigated the association between SES and mortality in the UK in 
people with type 1 diabetes and this is now nearly 20 years old [17].  
 
The aim of the present study was to investigate whether SES, determined by an area-based 
measure, was associated with mortality among people with type 1 diabetes over two time 
p riods and to describe mortality relative to that of the population without type 1 diabetes 
using recent national data for Scotland 
 
Participants and methods 
Data sources 
Population-based data for people with type 1 diabetes in Scotland were obtained from a 
2016 extract of the Scottish Care Information – Diabetes (SCI-Diabetes) database. This 
national database contains demographic and clinical data relevant to diabetes care. It is 
populated by daily downloads from primary and secondary care databases across Scotland. 
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The algorithm used to define type of diabetes for research purposes has been described 
previously [18]. Annual estimates of the numbers of people with type 1 diabetes and of 
numbers of deaths for 2006–2015 by age, sex and five SES groups were obtained from 
SCI-Diabetes.  
 
Socio-economic status was measured using the 2012 Scottish Index of Multiple 
Deprivation (SIMD), an area-based measure of SES [19]. It is a composite score that uses 
information from seven domains including income, education and crime to assign a 
deprivation score to each data zone. There are 6505 data zones across Scotland, with a 
median population of 769 people per data zone. These data zones are ranked according to 
their scores and divided into fifths, described as 'quintiles', with quintiles 1 and 5 
representing the 20% most and least deprived areas, respectively.  
 
Population and death data for the general population by age, sex, SIMD quintile and 




All people in the 2016 research extract of SCI-Diabetes with type 1 diabetes identified 
from the algorithm who were alive between 1 January 2006 and 31 December 2015 were 
included. Individuals were excluded if they had any of the following data missing: date of 
birth; sex; SIMD quintile; or date of type 1 diabetes diagnosis.   
 
The numbers of people and deaths in the type 1 diabetes population were subtracted from 
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sex, SIMD quintile and calendar year between 2011 and 2015 to identify numerators and 
denominators for the population without type 1 diabetes.  
 
Statistical analyses 
The cohort of people with type 1 diabetes was split into two time periods: 2006–2010 and 
2011–2015, in order to examine time trends with sufficiently large numbers of outcomes in 
age and sex subgroups. Descriptive data for each cohort are presented stratified by age 
(four categories: 0–39, 40–59, 60–79 and ≥80 years), sex and SIMD quintile.  
 
Sex-specific directly age-standardized mortality rates were calculated using the above four 
age groups for each SIMD quintile in both time periods using the European Standard 
Population 2013. Sex-specific analysis was undertaken as differences in mortality by sex in 
populations with type 1 diabetes that have been described previously [8,20].  
 
Rate differences and rate ratios for all-cause mortality between periods were calculated for 
each sex by subtraction of the age-standardized mortality rates for SIMD 1 and 5 and age-
adjusted Poisson regression for SIMD 1 compared to SIMD 5, respectively. Absolute and 
relative mortality for the population without type 1 diabetes and their differences by SIMD 
quintile were calculated using the same methods. In addition, sex-specific rate differences 
rate ratios were calculated to compare mortality between the population with type 1 
diabetes and the population without type 1 diabetes for the period 2011–2015. Interaction 
terms were included in Poisson models where appropriate.  
 
Ethics 
Approval for use of anonymized linked data for research, with a waiver for individual 
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11/AL/0225) and the Privacy Advisory Committee of National Health Service (NHS) 




A total of 37 169 people with type 1 diabetes were identified in the SCI-Diabetes extract. 
Of these, 238 people (0.6%) were excluded due to missing data. A further 3384 (9.1%) 
were excluded as they died prior to the study period or were diagnosed after the study 
period. Data remained for 33 547 eligible participants. In the 2006–2010 period there were 
1936 deaths during 130 972 person-years. In the 2011–2015 period there were 1866 deaths 
during 143 123 person-years. There were 271 356 deaths during 26 518 677 person-years 
of follow-up for the population without type 1 diabetes for 2011–2015. 
 
Characteristics of the three study populations are given in Table 1. There were small 
differences in age distribution in the cohorts with type 1 diabetes between the two time 
periods. Sex and SIMD distribution was similar in the two type 1 diabetes cohorts, with a 
higher proportion of men than women in both. Compared to populations with type 1 
diabetes, the population without type 1 diabetes had a more even balance of the sexes and a 




Age-standardized mortality rates for populations with type 1 diabetes, stratified by SIMD 
and calendar periods, are shown for men (Fig. 1) and women (Fig. 2). Age-standardized 
mortality rates for the population without type 1 diabetes for 2011–2015 are also presented. 
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deprivation. Within the population of people with type 1 diabetes, the age-standardized 
mortality rate decreased over time in every SES quintile, in both sexes. Smaller reductions 
in age-standardized mortality rate between time periods were seen in the most deprived 
quintile (13% for men and women), than in the least deprived quintile (24% for men and 
47% for women). Age-standardized mortality rates were higher for men than women in 
most SIMD quintiles. Compared to the population without type 1 diabetes, age-
standardized mortality rates were higher in the population with type 1 diabetes in every 
SIMD quintile, in both sexes.  
 
Absolute differences in age-standardized mortality rate between SIMD 1 and 5 in the 
populations, along with rate ratios are shown in Table 2. The age-standardized mortality 
rate was statistically significantly higher in the most deprived compared with the least 
deprived quintile for both sexes in all populations. In men with type 1 diabetes, the 
absolute rate difference between extreme SIMD quintiles decreased over time, with no 
evidence of a statistically significant interaction (P=0.422) despite increases in rate ratios 
over time. In women with type 1 diabetes, both absolute and relative differences in 
mortality by SES increased over time (P=0.018 for interaction between SIMD and period). 
Absolute rate differences and rate ratios between the most and least deprived SES groups 
were larger in the population with type 1 diabetes for 2011–2015 for both sexes than 
among the population without type 1 diabetes. 
 
Absolute differences in age-standardized mortality rate and rate ratios between the 
population with type 1 diabetes and population without type 1 diabetes for 2011–2015 for 
each SIMD quintile and sex are shown in Table 3. There were higher age-standardized 
mortality rates in the population with type 1 diabetes compared to the population without 
type 1 diabetes in all SES groups for both sexes. Rate ratios of mortality for type 1 diabetes 
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in the least deprived quintile (P for interaction <0.001) and were higher in women than 
men, with no evidence of an interaction (P=0.257).  
 
Discussion  
We found that mortality among people with type 1 diabetes declined over time and that 
socio-economic deprivation was positively associated with mortality in people with type 1 
diabetes in Scotland. Socio-economic inequalities in mortality among women with type 1 
diabetes appear to be widening over time. The socio-economic gradient in mortality was 
stronger in people with type 1 diabetes than in the general population.  
 
The finding of a mortality gradient according to SES is consistent with previous studies of 
populations with type 1 diabetes. A register-based study in Sweden conducted between 
2006 and 2012 found that people with type 1 diabetes in the lowest SES quintile had a 
relative risk of death of 2.60 (2.03–3.34) compared to people in the highest quintile [8]. 
Mortality gradients by SES have also been found in Finnish, US and Italian cohorts [9–11], 
with estimates ranging from 1.96 (1.78–2.17) [9] to 3.0 (1.2–7.8) [11] for comparisons 
between the lowest vs highest income groups or those without vs with college degrees, 
respectively. By comparison, our 2011–2015 estimate of the relative risks of mortality for 
people with type 1 diabetes from the most compared to the least deprived fifths of areas of 
Scotland was 2.81 (2.27–3.47) for men and 2.86 (2.22–3.69) for women. The studies from 
other countries used individual-level data on educational attainment, income and 
unemployment status to measure SES, whereas we used an area-based composite measure. 
These different approaches may contribute to the variation among results. Other 
differences among studies include healthcare systems, distributions of ethnicity within 
study populations and time period. Nevertheless, the consistent finding of a mortality 
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Numerous mechanisms may explain these findings. Known risk factors that are associated 
with increased mortality in type 1 diabetes include HbA1c, cholesterol, hypertension and 
microalbuminuria [21]. People with type 1 diabetes from low SES backgrounds are known 
to have higher HbA1c levels than their less deprived peers [21]. Socio-economic 
deprivation is also associated with unhealthy lifestyles such as smoking [22] and higher 
prevalence of elevated cholesterol levels, hypertension and microalbuminuria [8]. Intensive 
insulin regimes, involving tight management of blood glucose levels through frequent 
testing and multiple injections of insulin daily, reduce morbidity and mortality in type 1 
diabetes [23]. Uptake of these regimes is higher among more affluent SES groups [21]. 
Studies that have adjusted for risk factors have noted a decrease in the strength of 
association between SES and mortality compared to unadjusted analyses [8,11]. 
Nevertheless, the persistence of a relationship despite the adjustment suggests SES is an 
independent predictor of mortality in type 1 diabetes.   
 
The mechanisms behind the mortality disadvantage associated with socio-economic 
deprivation are therefore complex. These inequalities may be widening, as suggested by 
the increase in the relative risk of mortality between the most vs least deprived groups over 
time reported in the present study and in studies of the general population [5,6]. Although 
our results demonstrate the SES gradient in mortality and this trend over time in people 
with type 1 diabetes, further studies are required to delineate the underlying mechanisms, 
for example, by describing differences by SES in risk factor patterns and cause-specific 
mortality.  
 
Our demonstration that socio-economic inequalities in mortality appear to be greater in 
populations with type 1 diabetes than in the general population supports the findings of 
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health in the general population may be emphasized in type 1 diabetes. For example, levels 
of health literacy, defined as a person’s knowledge, motivation and competences to access, 
understand and apply information in order to make judgements in everyday life concerning 
healthcare, disease prevention and health promotion to maintain or improve quality of life 
during the life course, are lower in lower SES groups [24]. As a chronic condition that 
requires extensive self-care and lifestyle management, health literacy is key for successful 
management of type 1 diabetes. Interventions at both system and practitioner level can 
impact positively on health behaviours in those with low health literacy [25]. 
 
Initiatives such as access to structured education and to new technologies such as insulin 
pumps and flash glucose monitoring have the potential to improve management of type 1 
diabetes. However, their benefits may be more apparent in higher SES groups who possess 
the resources to facilitate their use [26]. A recent systematic review found that fewer than 
one-third of quality improvement trials included equity-relevant considerations, limiting 
their application to disadvantaged groups [27]. Ensuring that quality improvement 
initiatives consider their effects across socio-economic groups will help to ensure 
interventions are appropriate and will not inadvertently exacerbate inequalities. 
Interventions tailored towards disadvantaged populations may reduce disparities in 
diabetes care, however, a recent review was unable to draw strong conclusions about the 
potential benefits [28]. Furthermore, most of these studies were conducted in populations 
with type 2 diabetes and in the USA, whose health service is markedly different from that 
of the UK [27,28]. Further research to identify effective interventions to reduce socio-
economic inequalities in UK-based populations with type 1 diabetes are required to permit 
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Relative risks of all-cause mortality associated with type 1 diabetes in Scotland may have 
declined over time; overall rate ratios for 2005–2007 were 2.6 (95% CI 2.2–3.0) in men 
and 2.7 (95% CI 2.2–3.4) in women, whereas our estimates were 1.6 (95% CI 1.5–1.8) and 
1.8 (95% CI 1.7–2.0) for 2011–2015 [29]. These estimates are not directly comparable as 
the earlier study was limited to people aged >20 years and excluded those with type 2 
diabetes from the comparison population. Type 2 diabetes confers increased mortality 
relative to the general population [18]. Including people with type 2 diabetes in the 
population without type 1 diabetes will have resulted in underestimation of rate difference 
and rate ratios that would have been obtained if a population without either type of 
diabetes was used for comparison.  
 
We found that, among people with type 1 diabetes, men had a greater absolute risk of 
mortality than women at all SES levels; however, when compared to the population 
without type 1 diabetes, relative risks of death were greater for women than men, 
consistent with findings of previous studies [8,20].  
 
The present study has a number of strengths. The SCI-Diabetes database provides a 
nationwide cohort, for which data completeness is excellent, and mortality data for the 
whole study population are available from data linkage to national records. 
Misclassification of type of diabetes could be a source of information bias, particularly if 
this were differential by SES. However, data on the type of diabetes have been validated 
using the algorithm previously described. The nationwide cohort provides a large number 
of participants and power to detect differences, thus limiting the potential for type 2 errors.  
 
Limitations of this study include the fact that data on risk factors were not available from 
the population without diabetes to permit adjusted analyses. This would have allowed 
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Although age standardization helped to reduce confounding due to age differences between 
populations, the use of broad age categories may mean residual confounding was still 
present.  
 
The use of an area-based measure of deprivation, rather than an individual-based measure 
is a potential limitation as area-based measures may not fully reflect the SES of individuals 
[30]. Other measures of inequalities (such as the slope and relative index of inequality) are 
available, but we chose to present absolute and relative measures that are more familiar to 
a clinical audience.   
 
Our results provide a snapshot of the situation prior to the widespread implementation of 
new technologies such as insulin pumps. It would be interesting to repeat this study in the 
future to assess any impact on inequalities in mortality. Further research is also required to 
investigate the mechanisms underlying inequalities in populations with type 1 diabetes and 
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FIGURE 1  Age-standardized mortality rate (DSR) per Scottish Index of Multiple 
Deprivation (SIMD) quintile in Scotland for men with type 1 diabetes in the period 2006–
2010, men with type 1 diabetes in 2011–2015 and men without type 1 diabetes in 2011–
2015. 
FIGURE 2 Age-standardized mortality rate (DSR) per Scottish Index of Multiple 
Deprivation (SIMD) quintile in Scotland for women with type 1 diabetes in the period 
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Table 1  Distribution within Scotland of sociodemographic characteristics for people with type 1 diabetes between 2006 and 2010, people with type 1 diabetes between 2011 and 2015 and 
people without type 1 diabetes between 2011 and 2015  
 Type 1 diabetes 
  Population without 








P (Type 1 diabetes vs 
population without type 1 
diabetes for 2011–2015) 
Total person-years 130 972 143 123  26 518 677  
Men, n (%) 73 277 (56) 80 91 (56) 
0.43 
12 860 978 (49) 
<0.001 
Women, n 57 695 62 832 13 657 699 




Age category, n (% of 




0–39 years 64 012 (49) 66 275 (46) 
<0.001 
12 679 896 (48) 
<0.001 
40–59 years 47 566 (36) 53 616 (38) 7 532 359 (28) 
60–79 years 17 611 (13) 21 076 (15) 5 100 259 (19) 
≥80 years 1783 (1.4) 2156 (1.5) 1 206 163 (4.5)  
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1 26 426 (20) 28 791 (20) 
0.45 
5 329 014 (20) 
<0.001 
2 26 962 (21) 29 288 (21) 5 324 426 (20) 
3 27 581 (21) 29 945 (21) 5 306 098 (20) 
4 26 085 (20) 28 605 (20) 5 287 384 (20) 
5 23 918 (18) 26 494 (190) 5 271 755 (20) 
SIMD, Scottish Index of Multiple Deprivation. 
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Table 2   Absolute differences and rate ratios for comparisons of age-standardized or age-adjusted mortality rates between SIMD 1 and SIMD 5 in the study populations 
 
Type 1 diabetes Population without type 1 diabetes 
 
2006–2010 2011–2015 2011–2015 
Men 
   
Rate difference (95% CI) per 1000 person-years, DSR SIMD1 – DSR SIMD5 17.7 (16.3–19.1) 17.2 (15.9–18.5) 8.20 (7.20–9.20) 
Rate ratio (95% CI), SIMD1 vs  SIMD5 2.49 (2.02–3.06) 2.81 (2.27–3.47) 2.06 (2.03–2.10) 
    
Women 
   
Rate difference (95% CI) per 1000 person-years, DSR SIMD1 – DSR SIMD5 11.0 (9.6–12.4) 16.3 (15.1–17.5) 5.1 (4.2–6.0) 
Rate ratio (95% CI), SIMD1 vs  SIMD5 1.92 (1.52–2.39) 2.86 (2.22–3.69) 1.66 (1.63–1.69) 
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Table 3  Absolute rate differences and rate ratios for comparisons of age-standardized mortality rates between the Type 1 diabetes population and the population without type 1 diabetes for 
2011–2015, stratified by Scottish Index of Multiple Deprivation quintile  
 
Men Women 
SIMD 1 (most deprived) 
  
Rate difference (95% CI) per 1000 person-years 12.8 (11.5–14.1) 13.8 (12.6–15.0) 
Rate ratio (95% CI) 1.98 (1.77–2.22) 2.41 (2.11–2.77) 
SIMD 2 
  
Rate difference (95% CI) per 1000 person-years 10.5 (9.3–11.7) 9.2 (8.1–10.3) 
Rate ratio (95% CI) 2.04 (1.61–2.31) 2.29 (1.99–2.64) 
SIMD 3 
  
Rate difference (95% CI) per 1000 person-years 7.5 (6.4–8.6) 8.4 (7.4–9.4) 
Rate ratio (95% CI) 1.96 (1.72–2.24) 2.26 (1.94–2.62) 
SIMD 4 
  
Rate difference (95% CI)per 1000 person-years 5.7 (4.7 - 6.7) 7.8 (6.8–8.8) 
Rate ratio (95% CI) 1.95 (1.68–2.28) 2.20 (1.86– 2.60) 
SIMD 5 (least deprived) 
  
Rate difference (95% CI) per 1000 person-years 3.8 (2.9–4.7) 2.6 (1.8–3.4) 
Rate ratio (95% CI) 1.64 (1.37–1.95) 156 (1.26–1.93) 
SIMD, Scottish Index of Multiple Deprivation. 
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